Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The idiotype of the parent monoclonal antibody Ab1 refers to the unique set of antigenic determinants, or idiotopes, located within the variable region of an antibody (Ab1) that specifically recognizes a tumor-associated antigen (TAA) (Frontiers in Immunology, 2012). This target is a central element of Jerne's idiotypic network theory, which describes the immune system as a self-regulating web of interacting antibodies (NIH, 2025). In cancer immunotherapy, the Ab1 idiotype serves as the target for anti-idiotypic antibodies (Ab2), which are designed to mimic the structural conformation of the original TAA, acting as 'internal image' antigens (Creative Biolabs). When administered as a vaccine, the Ab2 antibody induces the production of anti-anti-idiotypic antibodies (Ab3) and T-cell responses that cross-react with the tumor cells, effectively bypassing immune tolerance to self-antigens (NIH, 1986). This approach has been utilized in the development of several cancer vaccines, such as Racotumomab and Abagovomab, to stimulate a targeted anti-tumor immune response (ResearchGate, 2019). Therapeutic challenges include the potential for a human anti-mouse antibody (HAMA) response and the need to ensure that the induced immune response specifically targets the tumor without causing significant autoimmunity (NIH, 1992).
Induction of an active immune response (Ab3) through the idiotypic network by mimicking a tumor-associated antigen.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Idiotype of the parent monoclonal antibody Ab1 (Ab1 idiotype).